PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.43%
Revenue growth 1.25-1.5x 3391.T's 3.70%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
-1.29%
Negative gross profit growth while 3391.T is at 3.50%. Joel Greenblatt would examine cost competitiveness or demand decline.
1.44%
EBIT growth below 50% of 3391.T's 47.36%. Michael Burry would suspect deeper competitive or cost structure issues.
-18.28%
Negative operating income growth while 3391.T is at 18.18%. Joel Greenblatt would press for urgent turnaround measures.
5.98%
Net income growth under 50% of 3391.T's 48.07%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.99%
EPS growth under 50% of 3391.T's 48.93%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
5.99%
Diluted EPS growth under 50% of 3391.T's 47.33%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.31%
10Y revenue/share CAGR under 50% of 3391.T's 74.12%. Michael Burry would suspect a lasting competitive disadvantage.
2.26%
5Y revenue/share CAGR under 50% of 3391.T's 59.44%. Michael Burry would suspect a significant competitive gap or product weakness.
-26.41%
Negative 3Y CAGR while 3391.T stands at 36.76%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
Positive long-term OCF/share growth while 3391.T is negative. John Neff would see a structural advantage in sustained cash generation.
100.00%
5Y OCF/share CAGR is similar to 3391.T's 100.00%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
No Data
No Data available this quarter, please select a different quarter.
108.41%
Below 50% of 3391.T's 287.45%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
54.75%
Below 50% of 3391.T's 264.20%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-17.52%
Negative 3Y CAGR while 3391.T is 137.18%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
63.41%
10Y equity/share CAGR at 50-75% of 3391.T's 91.64%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
33.94%
Below 50% of 3391.T's 75.78%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-10.40%
Negative 3Y equity/share growth while 3391.T is at 48.21%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.52%
Inventory growth well above 3391.T's 0.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.64%
Asset growth above 1.5x 3391.T's 2.15%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.81%
50-75% of 3391.T's 5.33%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
66.15%
We have some new debt while 3391.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
3.57%
We expand SG&A while 3391.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.